Massachusetts crossing $9 billion in legal cannabis sales proves that regulated markets work—generating tax revenue, creating jobs, and giving consumers access to safe, tested products. Marijuana legalization is on the primary election ballot in Texas, marking a significant moment for cannabis reform in one of the nation’s most conservative states and a major hemp-producing state. The ballot measure tests voter appetite for legalization in a state that has maintained strict cannabis laws while building a massive hemp industry.
First Human Clinical Trial: CBG Reduces Anxiety and Stress Without Intoxication
If Texas—one of America’s most conservative states and a major hemp producer—signals voter support for legalization, it could dramatically accelerate federal cannabis reform that affects your access to products. In one of the first double-blind, placebo-controlled clinical trials of isolated CBG in humans, a 20mg oral dose of hemp-derived cannabigerol produced statistically significant reductions in subjective anxiety and stress, along with improved verbal memory, without intoxication, cognitive slowing, or motor impairment. The study of 34 healthy adults suggests CBG may influence stress and anxiety pathways without producing typical ‘drug effects.’ Researchers emphasize preliminary nature and need for replication.